nateglinide

Known as: IPCCPA, nateglinide [Chemical/Ingredient], nate-glinide 
A phenylalanine derivative of the meglitinide class of agents with hypoglycemic activity. Nateglinide, compared to repaglitinide, binds with a higher… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2018
010203019982018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
BACKGROUND The ability of short-acting insulin secretagogues to reduce the risk of diabetes or cardiovascular events in people… (More)
  • figure 1
  • table 1
  • table 1
  • table 1
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
  • 2010
Methods In this double-blind, randomized clinical trial with a 2-by-2 factorial design, we assigned 9306 patients with impaired… (More)
  • figure 1
  • table 1
  • table 1
  • table 1
  • figure 2
Is this relevant?
2006
2006
AIMS Nateglinide is a meglitinide analogue with antidiabetic action. A recent study showed that SLCO1B1 (which codes the OATP1B1… (More)
Is this relevant?
2005
2005
OBJECTIVE To compare long-term efficacy and safety of initial combination therapy with nateglinide/metformin versus glyburide… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Loss of beta-cell mass and function raises a concern regarding the application of sulfonylureas for the treatment of type 2… (More)
Is this relevant?
2004
2004
OBJECTIVE A randomized, parallel-group, open-label, multicenter 16-week clinical trial compared efficacy and safety of… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE Insulin resistance is an independent risk factor for arteriosclerosis and cardiovascular mortality. However, the… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2001
2001
The pharmacokinetics and metabolism of nateglinide were studied in six healthy male subjects receiving a single oral (120 mg) and… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To evaluate the efficacy and tolerability of nateglinide and metformin alone and in combination in type 2 diabetic… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
2000
2000
OBJECTIVE The objective of the study was to assess the efficacy and safety of four fixed doses of nateglinide compared with… (More)
Is this relevant?